Capkun G - Search Results

1

NASHmap: clinical utility of a machine learning model to identify patients at risk of NASH in real-world settings.

Schattenberg JM, Balp MM, Reinhart B, Tietz A, Regnier SA, Capkun G, Ye Q, Loeffler J, Pedrosa MC, Docherty M. Schattenberg JM, et al. Among authors: capkun g. Sci Rep. 2023 Apr 5;13(1):5573. doi: 10.1038/s41598-023-32551-2. Sci Rep. 2023. PMID: 37019931 Free PMC article.

2

Development of a novel machine learning model to predict presence of nonalcoholic steatohepatitis.

Docherty M, Regnier SA, Capkun G, Balp MM, Ye Q, Janssens N, Tietz A, Löffler J, Cai J, Pedrosa MC, Schattenberg JM. Docherty M, et al. Among authors: capkun g. J Am Med Inform Assoc. 2021 Jun 12;28(6):1235-1241. doi: 10.1093/jamia/ocab003. J Am Med Inform Assoc. 2021. PMID: 33684933 Free PMC article.

3

Expanding the use of administrative claims databases in conducting clinical real-world evidence studies in multiple sclerosis.

Capkun G, Lahoz R, Verdun E, Song X, Chen W, Korn JR, Dahlke F, Freitas R, Fraeman K, Simeone J, Johnson BH, Nordstrom B. Capkun G, et al. Curr Med Res Opin. 2015 May;31(5):1029-39. doi: 10.1185/03007995.2015.1014029. Epub 2015 Mar 4. Curr Med Res Opin. 2015. PMID: 25661016

4

Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis.

Bergvall N, Petrilla AA, Karkare SU, Lahoz R, Agashivala N, Pradhan A, Capkun G, Makin C, McGuiness CB, Korn JR. Bergvall N, et al. Among authors: capkun g. J Med Econ. 2014 Oct;17(10):696-707. doi: 10.3111/13696998.2014.940422. Epub 2014 Jul 23. J Med Econ. 2014. PMID: 25019581 Free article.

5

Development and validation of a Bayesian survival model for inclusion body myositis.

Capkun G, Schmidt J, Ghosh S, Sharma H, Obadia T, de Vera A, Risson V, Amzal B. Capkun G, et al. Theor Biol Med Model. 2019 Nov 7;16(1):17. doi: 10.1186/s12976-019-0114-4. Theor Biol Med Model. 2019. PMID: 31694651 Free PMC article.

6

Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis.

Bergvall N, Makin C, Lahoz R, Agashivala N, Pradhan A, Capkun G, Petrilla A, Karkare SU, Balderston McGuiness C, Korn JR. Bergvall N, et al. Among authors: capkun g. Curr Med Res Opin. 2013 Dec;29(12):1647-56. doi: 10.1185/03007995.2013.847411. Epub 2013 Oct 1. Curr Med Res Opin. 2013. PMID: 24059944

7

Modelling Decline in Cognition to Decline in Function in Alzheimer's Disease.

Karcher H, Savelieva M, Qi L, Hummel N, Caputo A, Risson V, Capkun G, Alzheimer's Disease Neuroimaging Initiative. Karcher H, et al. Among authors: capkun g. Curr Alzheimer Res. 2020;17(7):635-657. doi: 10.2174/1567205017666201008105429. Curr Alzheimer Res. 2020. PMID: 33032508

8

Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making?

Capkun G, Corry S, Dowling O, Asad Zadeh Vosta Kolaei F, Takyar S, Furtado C, Jónsson P, Kleinermans D, Lambert L, Schiel A, Facey K. Capkun G, et al. Int J Technol Assess Health Care. 2022 Nov 2;38(1):e79. doi: 10.1017/S0266462322000605. Int J Technol Assess Health Care. 2022. PMID: 36321447

9

Relapse rates in patients with multiple sclerosis switching from interferon to fingolimod or glatiramer acetate: a US claims database study.

Bergvall N, Makin C, Lahoz R, Agashivala N, Pradhan A, Capkun G, Petrilla AA, Karkare SU, McGuiness CB, Korn JR. Bergvall N, et al. Among authors: capkun g. PLoS One. 2014 Feb 6;9(2):e88472. doi: 10.1371/journal.pone.0088472. eCollection 2014. PLoS One. 2014. PMID: 24516663 Free PMC article.

10

New opportunities of real-world data from clinical routine settings in life-cycle management of drugs: example of an integrative approach in multiple sclerosis.

Rothenbacher D, Capkun G, Uenal H, Tumani H, Geissbühler Y, Tilson H. Rothenbacher D, et al. Among authors: capkun g. Curr Med Res Opin. 2015 May;31(5):953-65. doi: 10.1185/03007995.2015.1027677. Epub 2015 Apr 2. Curr Med Res Opin. 2015. PMID: 25758179

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters